The current clinical study follows on from two, small-group pilot studies which produced significant results of positive clinical benefits to patients administered magnesium orotate, and orotate in combination with probiotic strains.
“We are hoping to see those results replicated in a larger cohort.”
- Forums
- ASX - By Stock
- MDC
- Ann: Recruitment Begins - Phase 2A Trial for Depression Medicine
Ann: Recruitment Begins - Phase 2A Trial for Depression Medicine, page-4
Featured News
Add MDC (ASX) to my watchlist
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable